Adam Morgan, Director at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 1,766,546 shares at $1.50 ($2.6M) on 2025-08-08, disclosed to the SEC on 2025-08-12.
Open-market purchase of $2.6M HRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |